Deal Alert: Established Clinical Research Organization

📍 Location: [Undisclosed]
💰 Asking Price: [not disclosed]
📊 Revenue: $10M in Signed Contracts
💼 Net Profit: [Not Disclosed]

🌟 Why This Business is Great:

Long-standing Industry Reputation:

This Contract Research Organization (CRO) has been a trusted partner in the pharmaceutical and medical device industries for over 25 years. With a strong track record in clinical trial management, from pre-clinical phases through Phase 4, this business has built a reputation for reliability and excellence. The longevity and stability of this CRO make it a valuable asset for any potential acquirer, especially in an industry where trust and experience are paramount.

Diversified Revenue Streams:

Serving clients across the U.S., Canada, and Europe, Prosoft Clinical benefits from a diversified revenue stream. This geographic spread not only mitigates risk but also positions the business to capitalize on varying market dynamics across different regions. The inclusion of proprietary systems like eDC, IWRS, and AdaptIQ enhances the service offering and opens up potential licensing opportunities, adding an additional layer of revenue potential.

Solid Financial Backlog:

With a $10M backlog in signed contracts and an additional $1M in new consulting revenue, this business is financially robust and poised for growth. The strong pipeline of work provides immediate revenue security, ensuring the incoming owner has a solid foundation to build upon. This financial security is a significant advantage in the often volatile clinical research sector.

🚀 Growth Potential:

Post-Pandemic Rebound:

Despite a temporary dip during the COVID-19 pandemic, the company is on track to rebound strongly in 2024, potentially exceeding pre-pandemic revenue levels of $7M. This resilience underscores the business's ability to adapt to market fluctuations and suggests that with the right strategic vision, there is significant potential for future growth.

Expansion and Licensing Opportunities:

One of the most exciting aspects of this CRO is its untapped potential in licensing proprietary technology and expanding into new therapeutic areas. With a client base largely built on word of mouth, the business already enjoys high levels of trust and satisfaction. A focused marketing strategy could amplify these strengths, driving both top-line growth and profitability.

🔍 My Analysis: This clinical research organization is a standout opportunity for anyone looking to invest in or expand within the CRO industry. With over 25 years of experience, the business has built a strong reputation and a diverse client base across the U.S., Canada, and Europe. The $10M in signed contracts and $1M in new consulting revenue provide a solid financial foundation, while the potential for growth—particularly through licensing their proprietary technology and expanding into new therapeutic areas—is significant. The owner's nearing retirement and commitment to a smooth transition make this an ideal time to acquire a business with both stability and substantial upside potential.

🏃‍♂️Take Action: If you want access to this deal and others like it, book a call with us. We'll show you how to get the contact detail, show you how to analyze this deal or others you want, and discuss our paid programs so we could help you find, finance, and acquire a business.

Discover Our Acquisitions Advisory Success: learn our strategies for buying and selling businesses, for monthly retainers, and 2-10% of each deal at deal closing.

Together with Money Pickle

Retirement Isn’t the Opposite of Childhood After All

Remember those magazine quizzes we all loved as teens? Whether it was predicting your future spouse or discovering your perfect style, they were all about uncovering something new. Fast forward to today—while your dreams may now focus on financial security rather than pop stardom, there’s still room for a good quiz.

What if you could benefit from a financial advisor but just don’t know it? Sure, you could go through the hassle of finding and vetting advisors yourself, only to wonder if you’re missing out on something better. Or, you could take Money Pickle’s Retirement Quiz to see if talking to a financial advisor is right for you.

Our quiz is designed to match you with a trusted, vetted advisor who already works with people in situations similar to yours. Don’t stress or wonder what you could be doing differently—take the quiz to see how you can benefit from personalized advice on investments, tax-saving strategies, and estate planning. Then, have a free, flexible video or phone call from the comfort of your home to explore your options.

You can [find the free quiz—and more resources—on Money Pickle’s website]. It’s a modern twist on those nostalgic quizzes, but with real financial benefits. Just don’t forget your gel pen.

Recent Case Study

Alaric gets equity for his growth consulting [link]

Recent Acquisition Stories:
Quest Diagnostics Expands North with LifeLabs Acquisition

Quest Diagnostics has successfully completed its acquisition of Canadian lab services provider LifeLabs for CAN$1.35 billion (approximately $1 billion USD). LifeLabs, previously owned by the Ontario Municipal Employees Retirement System (OMERS), will continue to operate under its existing management team, ensuring a smooth transition and continuity in operations.

My Take on Quest's Strategic Move into Canada

This acquisition marks a significant expansion for Quest Diagnostics into the Canadian market, strengthening its presence in North America. By acquiring LifeLabs, Quest not only broadens its geographical footprint but also gains access to a well-established network in Canada's healthcare sector. This move aligns with Quest’s growth strategy, allowing the company to leverage LifeLabs' infrastructure and relationships in a new market.

What This Acquisition Means for the Industry

From an industry perspective, this acquisition could signal increased consolidation in the lab services sector as companies like Quest look to expand their influence and reach. This could lead to more competitive pricing and enhanced service offerings as these larger entities continue to grow and innovate. For Quest, this acquisition is a clear step towards becoming a dominant player in North America, potentially setting the stage for future growth and expansion.

Scale or Sell

If you're a business owner looking to scale your company to 8 or 9 figures, we can help. Our 70+ pillars alongside our “Scale or Sell” system provides a clear roadmap to improve your operations and profitability while preparing for future rollups & acquisitions. Book a call with us to get personalized guidance, access our proprietary growth tools, and learn how to build a valuable, sellable enterprise.

Recent Youtube Video

Trend Spotting The Next Billion Dollar Industry [link]

Here’s How We Can Help You:

• Join Our Community: Access free courses & meet fellow entrepreneurs. (link)

• Buy a Business: Get support with finding, analyzing & financing deals (link)

• Become an Acquisitions.com Advisor: Help others buy and sell businesses. (link)

• Scale your business: Build Internal foundations before external growth (link)

• Sell a Business: Connect with interested buyers. (link)

• Co-invest with Us: Partner on lucrative deals. (link)